Panalpina has obtained Good Distribution Practice (GDP) certification for its logistics centre in Singapore, making it the 32nd GDP certified location.
The certificate was issued by Singapore’s Health Sciences Authority (HSA), having demonstrated compliance with HSA GDP guidelines.
With the certificate, Panalpina is authorised to store, handle and distribute medicines in the local market and ship them abroad on behalf of pharmaceutical companies.
Panalpina managing director for Singapore and Malaysia, Gino Marzola says: “The pharmaceutical sector in Singapore has developed enormously since 2000 and the companies are increasingly outsourcing the logistics for their highly sensitive products.
“Healthcare supply chains have a zero-fault tolerance, and the GDP certification for our brand-new facility demonstrates that we can meet that requirement. We also give pharmaceutical companies access to a global, quality distribution network for their products.”
According to the Singapore Economic Development Board, eight of the top 10 pharmaceutical companies have a presence in Singapore, with the sector producing more than S$16 billion worth of products a year.
